Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Angel Yeast is the world’s second-largest yeast producer with a global market share exceeding 15%. It has over three decades of experience in yeast biotechnology. The company has robust R&D capabilities with more than a dozen research centers worldwide. Its portfolio includes baker’s yeast, nutritional yeasts/extracts, enzymes, probiotics, biofuels inputs, animal nutrition ingredients, plant nutrition solutions and emerging synthetic biology products such as vitamin K2. It collaborates with leading companies like Novozymes and Chr. Hansen to advance enzyme applications and probiotic formulations. Recent initiatives include building an integrated synthetic biology industry cluster focused on next-generation bio-manufacturing.[1][2][3][4]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Angel Yeast.